Notably, patients whose melanoma specimens showed high NACC1 and FKBP10 expression exhibited the worst overall survival, and those specimens also exhibited the highest NR2F6 expression relative to specimens expressing low NACC1 and FKBP10 (Fig. 6, E and F). This evidence concerns the gene FKBP10 and melanoma.